what glp-1 drugs are fda approved for weight loss How Employers Can Optimize Benefits in the Era of GLP-1s The New Weight Management Meds

This discrepancy between controlled trials and real-world evidence highlights the complexities of translating trial findings to diverse patient populations

Acute kidney injury has been reported, typically in the context of severe dehydration from gastrointestinal side effects

GLP-1 receptor agonists potential therapeutic effects appear to target key pathological mechanisms of PD directly

Identifying molecular or imaging biomarkers in this patient population could facilitate earlier diagnosis, enable targeted interventions, and support the monitoring of disease progression

The popularity of the platform will likely translate into more people being prescribed Zepbound for weight loss

Due to the increasing popularity of GLP-1RAs in patients with obesity, we call for further high-quality studies to address the optimal perioperative care of patients on GLP-1RAs.